CFO, Senior Vice President of Finance, Secretary
Mr. Charles J. Cashion is Chief Financial Officer, Senior Vice President of Finance, Secretary of Conatus Pharmaceuticals Inc., since July 2005. From 2001 to 2005, he was Chief Financial Officer at Idun. He has held several senior level management positions in both private and public healthcare companies with responsibilities for securing and executing various types of financings including initial public offerings, secondary offerings, corporate partnerships, and debt. He has also been involved with the strategic planning, acquisition and integration of several technology companies. He joined Idun Pharmaceuticals in 2001 as Executive Vice President, Chief Financial Officer and Secretary. Previously, he held the position of Senior Vice President and Chief Financial Officer of Quidel Corporationrationration, a publiclyheld medical diagnostics company. For the prior nine years, he was Senior Vice President, Finance, and Chief Financial Officer of The Immune Response Corporationrationration, a publiclyheld biopharmaceutical company. During the period from 1980 to 1989, he was Executive Vice President and Chief Financial Officer of Smith Laboratories, Inc., a publiclyheld pharmaceutical company and during 1987 through 1989 was also President and Chief Executive Officer of Sutter Corporationrationration, an orthopedic products subsidiary of Smith Laboratories. He also held positions at Baxter International, Inc. and Motorola, Inc. He serves on the boards of directors of NovaBay Pharmaceuticals, Inc., Ridge Diagnostics, Inc., La Jolla Institute for Allergy Immunology, and iDiverse, Inc
Age: 64 President Since 2005 MBACashion holds an M.B.A. and B.S. in Accounting from Northern Illinois University.